REGENERON PHARMACEUTICALS, INC. (REGN)

Import this data to Google Sheets with:

=jivedata("REGN","financials")

Full statements spill as a table. For one cell: =jivedata("REGN","Revenue") or =jivedata("REGN","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

REGENERON PHARMACEUTICALS, INC.

REGN • CIK 0000872589

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Liabilities and Equity	$33,080,200	$37,759,400	$40,558,700	$41,730,600
Marketable Securities, Noncurrent	$5,396,500	$8,900,100	$10,260,600	$9,828,300
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	$4,146,400	$4,599,700	$5,120,400	$5,458,900
Intangible Assets, Net (Excluding Goodwill)	$1,038,600	$1,148,600	$1,257,400	$1,309,800
Deferred Income Tax Assets, Net	$2,575,400	$3,314,100	$4,077,200	$4,381,400
Other Assets, Noncurrent	$444,100	$1,136,000	$1,821,200	$2,306,200
Long-term Debt, Excluding Current Maturities	$1,982,900	$1,984,400	$1,985,900	$1,986,600
Finance Lease, Liability, Noncurrent	$720,000	$720,000	$720,000	$0
Contract with Customer, Liability, Noncurrent	$126,700	$185,700	$208,700	$220,400
Other Liabilities, Noncurrent	$854,100	$1,571,400	$2,018,800	$2,281,600
Liabilities	$7,107,100	$8,405,800	$9,301,800	$10,019,200
Cash and Cash Equivalents, at Carrying Value	$2,730,000	$2,488,200	$3,118,100	$2,455,800
Marketable Securities, Current	$8,114,800	$6,524,300	$5,487,100	$5,538,800
Accounts Receivable, after Allowance for Credit Loss, Current	$5,667,300	$6,211,900	$5,741,100	$6,565,400
Inventory, Net	$2,580,500	$3,087,300	$3,200,800	$3,084,300
Prepaid Expense and Other Assets, Current	$386,600	$349,200	$474,800	$801,700
Assets, Current	$19,479,200	$18,660,900	$18,021,900	$18,446,000
Accounts Payable, Current	$606,600	$789,500	$939,000	$1,159,300
Accrued Liabilities and Other Liabilities	$2,357,900	$2,527,100	$2,876,400	$2,966,500
Contract with Customer, Liability, Current	$458,900	$627,700	$553,000	$684,800
Liabilities, Current	$3,423,400	$3,944,300	$4,368,400	$5,530,600
Preferred Stock, Value, Issued	$0	$0	$0	$0
Additional Paid in Capital	$11,354,000	$12,855,900	$13,995,000	$14,700,600
Retained Earnings (Accumulated Deficit)	$27,260,300	$31,672,900	$35,797,100	$37,621,400
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-80,900	$-7,900	$77,500	$-35,800
Treasury Stock, Common, Value	$12,560,400	$15,167,400	$18,612,800	$20,574,900
Stockholders' Equity Attributable to Parent	$25,973,100	$29,353,600	$31,256,900	$31,711,400
Preferred Stock, Shares Authorized	30,000,000	30,000,000	30,000,000	30,000,000
Preferred Stock, Shares Issued	0	0	0	0
Treasury Stock, Common, Shares	25,500,000	28,200,000	33,700,000	36,400,000
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	$605,700	$591,200	$576,700	$576,700
Operating Lease, Right-of-Use Asset	$78,000	$217,400	$245,800	$245,800
Finance Lease, Right-of-Use Asset, Accumulated Amortization	$133,900	$148,400	$162,900	$162,900
Operating Lease, Liability, Current	$19,000	$30,300	$37,800	$37,800
Operating Lease, Liability, Noncurrent	$68,700	$204,100	$229,000	$229,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$3,953,600	$4,412,600	$4,504,900	$4,328,700
Net Cash Provided by (Used in) Operating Activities	$4,594,000	$4,420,500	$4,978,900	$4,681,300
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$-400	$-700	$300	$-1,900
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-381,600	$-248,800	$634,700	$450,400
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$2,737,800	$2,489,000	$3,123,700	$3,001,300
Depreciation, Depletion and Amortization	$421,000	$482,900	$543,700	$528,600
Payments to Acquire Marketable Securities	$11,646,000	$16,617,400	$10,958,300	$10,269,900
Share-based Payment Arrangement, Noncash Expense	$885,000	$982,800	$993,700	$986,700
Proceeds from Sale and Maturity of Marketable Securities	$9,442,200	$15,027,300	$11,546,200	$10,675,100
Payments to Acquire Productive Assets	$718,600	$755,900	$898,400	$920,900
Other Noncash Income (Expense)	$100	$-23,500	$-135,500	$-263,700
Proceeds from Sale of Property, Plant, and Equipment	—	$20,100	$0	$0
Increase (Decrease) in Deferred Income Taxes	$837,800	$757,300	$785,400	$801,500
Payments to Acquire Businesses, Net of Cash Acquired	$54,900	$16,500	$3,300	$3,300
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities	$640,400	$7,900	$474,000	$352,600
Net Cash Provided by (Used in) Investing Activities	$-3,185,100	$-2,468,100	$-629,100	$-704,200
Proceeds from Issuance of Common Stock	$1,145,500	$1,465,300	$635,900	$756,100
Payment, Tax Withholding, Share-based Payment Arrangement	$700,600	$1,029,100	$532,100	$603,000
Payments for Repurchase of Common Stock	$2,235,000	$2,603,300	$3,438,600	$3,299,400
Payments of Dividends	—	—	$370,300	$378,500
Proceeds from (Payments for) Other Financing Activities	—	$-33,400	$-10,300	$0
Net Cash Provided by (Used in) Financing Activities	$-1,790,100	$-2,200,500	$-3,715,400	$-3,524,800
Interest Paid, Excluding Capitalized Interest, Operating Activities	$73,100	$52,600	$41,600	$41,600
Increase (Decrease) in Accounts Receivable	$338,800	$554,000	$-498,100	$968,800
Increase (Decrease) in Inventories	$271,700	$619,700	$275,300	$82,100
Increase (Decrease) in Prepaid Expense and Other Assets	$120,100	$407,500	$375,300	$482,800
Increase (Decrease) in Contract with Customer, Liability	$37,900	$227,800	$-51,700	$217,000
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$598,600	$735,100	$736,800	$1,334,900
Operating Lease, Payments	$22,500	$41,400	$39,600	$39,600
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$31,900	$188,100	$59,100	$59,100
Cash and Cash Equivalents, at Carrying Value	$2,730,000	$2,488,200	$3,118,100	$2,990,500
Restricted Cash, Current	—	$800	$5,600	$10,800
Restricted Cash, Noncurrent	$7,800	$0	$0	$0
Capital Expenditures Incurred but Not yet Paid	$75,400	$151,600	$178,800	$235,100

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("REGN","financials")

Full statements spill as a table. For one cell: =jivedata("REGN","Revenue") or =jivedata("REGN","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.